Literature DB >> 25555821

Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies.

Konstantinos K Tsilidis1, John C Kasimis2, David S Lopez3, Evangelia E Ntzani2, John P A Ioannidis4.   

Abstract

OBJECTIVES: To summarise the evidence and evaluate the validity of the associations between type 2 diabetes and the risk of developing or dying from cancer.
DESIGN: An umbrella review of the evidence across meta-analyses of observational studies of type 2 diabetes with risk of developing or dying from any cancer. DATA SOURCES: PubMed, Embase, Cochrane database of systematic reviews, and manual screening of references. ELIGIBILITY CRITERIA: Meta-analyses or systematic reviews of observational studies in humans that examined the association between type 2 diabetes and risk of developing or dying from cancer.
RESULTS: Eligible meta-analyses assessed associations between type 2 diabetes and risk of developing cancer in 20 sites and mortality for seven cancer sites. The summary random effects estimates were significant at P=0.05 in 20 meta-analyses (74%); and all reported increased risks of developing cancer for participants with versus without diabetes. Of the 27 meta-analyses, eventually only seven (26%) compiled evidence on more than 1000 cases, had significant summary associations at P ≤ 0.001 for both random and fixed effects calculations, and had neither evidence of small study effects nor evidence for excess significance. Of those, only six (22%) did not have substantial heterogeneity (I(2)>75%), pertaining to associations between type 2 diabetes and risk of developing breast, cholangiocarcinoma (both intrahepatic and extrahepatic), colorectal, endometrial, and gallbladder cancer. The 95% prediction intervals excluded the null value for four of these associations (breast, intrahepatic cholangiocarcinoma, colorectal, and endometrial cancer).
CONCLUSIONS: Though type 2 diabetes has been extensively studied in relation to risk of developing cancer and cancer mortality and strong claims of significance exist for most of the studied associations, only a minority of these associations have robust supporting evidence without hints of bias. © Tsilidis et al 2014.

Entities:  

Mesh:

Year:  2015        PMID: 25555821     DOI: 10.1136/bmj.g7607

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  230 in total

1.  Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium.

Authors:  Yu Chen; Fen Wu; Eiko Saito; Yingsong Lin; Minkyo Song; Hung N Luu; Prakash C Gupta; Norie Sawada; Akiko Tamakoshi; Xiao-Ou Shu; Woon-Puay Koh; Yong-Bing Xiang; Yasutake Tomata; Kemmyo Sugiyama; Sue K Park; Keitaro Matsuo; Chisato Nagata; Yumi Sugawara; You-Lin Qiao; San-Lin You; Renwei Wang; Myung-Hee Shin; Wen-Harn Pan; Mangesh S Pednekar; Shoichiro Tsugane; Hui Cai; Jian-Min Yuan; Yu-Tang Gao; Ichiro Tsuji; Seiki Kanemura; Hidemi Ito; Keiko Wada; Yoon-Ok Ahn; Keun-Young Yoo; Habibul Ahsan; Kee Seng Chia; Paolo Boffetta; Wei Zheng; Manami Inoue; Daehee Kang; John D Potter
Journal:  Diabetologia       Date:  2017-03-07       Impact factor: 10.122

2.  GLP-1 receptor agonists and risk of cancer in type 2 diabetes: an updated meta-analysis of randomized controlled trials.

Authors:  Chuqing Cao; Shuting Yang; Zhiguang Zhou
Journal:  Endocrine       Date:  2019-08-16       Impact factor: 3.633

Review 3.  Insights into the relationships between diabetes, prediabetes, and cancer.

Authors:  Lorenzo Scappaticcio; Maria Ida Maiorino; Giuseppe Bellastella; Dario Giugliano; Katherine Esposito
Journal:  Endocrine       Date:  2016-12-31       Impact factor: 3.633

4.  Examining Colorectal Cancer Risk Awareness and Food Shelf Use Among Health Center Patients.

Authors:  Ogechi J Obidike; Charles R Rogers; Caitlin E Caspi
Journal:  J Racial Ethn Health Disparities       Date:  2019-06-05

Review 5.  Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD.

Authors:  Helen L Reeves; Marco Y W Zaki; Christopher P Day
Journal:  Dig Dis Sci       Date:  2016-02-26       Impact factor: 3.199

Review 6.  Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease.

Authors:  Alessandro Mantovani; Giovanni Targher
Journal:  Ann Transl Med       Date:  2017-07

7.  Editorial: Mendelian Randomization Analysis Identifies Body Mass Index and Fasting Insulin as Potential Causal Risk Factors for Pancreatic Cancer Risk.

Authors:  Konstantinos K Tsilidis; James Y Dai; Ulrike Peters
Journal:  J Natl Cancer Inst       Date:  2017-09-01       Impact factor: 13.506

8.  Insulin Resistance and Cancer-Specific and All-Cause Mortality in Postmenopausal Women: The Women's Health Initiative.

Authors:  Kathy Pan; Rebecca A Nelson; Jean Wactawski-Wende; Delphine J Lee; JoAnn E Manson; Aaron K Aragaki; Joanne E Mortimer; Lawrence S Phillips; Thomas Rohan; Gloria Y F Ho; Nazmus Saquib; Aladdin H Shadyab; Rami Nassir; Jinnie J Rhee; Arti Hurria; Rowan T Chlebowski
Journal:  J Natl Cancer Inst       Date:  2020-02-01       Impact factor: 13.506

Review 9.  Cardio-oncology Related to Heart Failure: Common Risk Factors Between Cancer and Cardiovascular Disease.

Authors:  Anne Blaes; Anna Prizment; Ryan J Koene; Suma Konety
Journal:  Heart Fail Clin       Date:  2017-04       Impact factor: 3.179

Review 10.  Shared Risk Factors in Cardiovascular Disease and Cancer.

Authors:  Ryan J Koene; Anna E Prizment; Anne Blaes; Suma H Konety
Journal:  Circulation       Date:  2016-03-15       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.